Copyright
©The Author(s) 2024.
World J Gastroenterol. Feb 28, 2024; 30(8): 901-918
Published online Feb 28, 2024. doi: 10.3748/wjg.v30.i8.901
Published online Feb 28, 2024. doi: 10.3748/wjg.v30.i8.901
Figure 5 Metadherin downregulation inhibits hepatocellular carcinoma stem cell phenotypes.
A: mRNA expression of Metadherin (MTDH), CD133, Nanog, and Oct4 in 97H and Huh7-RNAi; B: In comparison with that of MTDH-LV-RNAi, the protein expression of CD133 and Nanog was elevated in MHCC-97H-NC and Huh7-NC cells; C: Images depicting sphere formation by 97H-RNAi and Huh7-RNAi cells; D: Immunofluorescence images of Nanog (red) in 97H-LV and Huh7-LV samples. DAPI (blue) was used to stain the nuclei. aP < 0.05, bP < 0.01, cP < 0.001. RNAi: Metadherin knockdown group; RNAi-NC: Metadherin knockdown control group.
- Citation: Wang YY, Shen MM, Gao J. Metadherin promotes stem cell phenotypes and correlated with immune infiltration in hepatocellular carcinoma. World J Gastroenterol 2024; 30(8): 901-918
- URL: https://www.wjgnet.com/1007-9327/full/v30/i8/901.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i8.901